Acute complications of dopamine agonist treatment for macroprolactinoma - How uncommon?

Journal of Clinical Neuroscience

Volumn 11, Issue 8, 2004, Pages 825-828

  Nadesapillai, Subanesan ^a   Balcere, Inga ^a   Kaye, Andrew H ^a   Tress, Brian M ^b   Colman, Peter G ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

apoplexy; dopamine agonist; macroprolactinoma complications; meningitis

Indexed keywords

ACICLOVIR; BROMOCRIPTINE; CABERGOLINE; CEFTRIAXONE; CORTISONE; DEXAMETHASONE; DOPAMINE RECEPTOR STIMULATING AGENT; PENICILLIN G; PERGOLIDE; STEROID; TESTOSTERONE ENANTATE; THYROXINE;

ADULT; ANAMNESIS; BLOOD PRESSURE MONITORING; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REGIMEN; DRUG ERUPTION; EARLY DIAGNOSIS; HEART RATE VARIABILITY; HUMAN; HYPOPHYSIS APOPLEXY; HYPOPHYSIS TUMOR; LABORATORY TEST; LUMBAR PUNCTURE; MALE; MENINGITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN SATURATION; PHOTOPHOBIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROLACTINOMA; REVIEW; RHINORRHEA; VISUAL FIELD;

EID: 7444228186     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2004.03.002     Document Type: Article

References (11)

1. Hewage U.C.L., Colman P.G., Kaye A. Cerebrospinal fluid rhinorrhoea occuring six days after commencement of bromocriptine for invasive prolactinoma. Aust. N Z. J. Med. 30:2000;399-400
2. Leong K.S., Foy P.M., Swift A.C., Atkin S.L., Hadden D.R., MacFarlane I.A. CSF rhinorrhoea following treatment with dopamine agonist for massive invasive prolactinomas. Clin. Endocrinol. 52:2000;43-49
3. Hildebrandt G., Zierski J., Christophis P., et al. Rhinorrhoea following dopamine agonist therapy of invasive macroprolactinomas. Acta Neurochir. (Wien). 96:1989;107-113
4. Barlas O., Bayindir C., Hepguil K., Can M., Kiris T., Sencer E., et al. Bromocriptine induced cerebrospinal fluid fistula in patients with macroprolactinoma: report of three cases and a review of the literature. Surg. Neurol. 41:1994;486-489
5. Cappabianca P., Lodrini S., Felisati G., Peca C., Cozzi R., Di Sarno A., et al. Cabergoline-induced CSF rhinorrhoea in patients with macroprolactinoma. Report of three cases. J. Endocrinol. Invest. 24:2001;183-187
6. Wood R., Sandeman D.D. Meningitis four years after treatment of macroprolactinoma. J. R. Soc. Med. 95:2002;501-502
7. Pascal-Vigneron V., Weryha G., Braun M., Morel-Jean J., Bisset S., Laclere J. Rhinorrhoea and otorrhoea: rare complications of the medical treatment of invasive prolactinomas. Ann. Endocrinol. (Paris). 54:1994;347-351
8. Davis J.R.E., Sheppard M.C., Health D.A. Giant invasive prolactinoma: A case report and review of nine further cases. Quart. J. Med. 74:1990;227-238
9. Wakai S., Fukushima T., Treamoto A., Sano K. Pituitary apoplexy: its incidence and clinical significance. J. Neurosurg. 55:1981;187-193
10. Pinto G., Zerah M., Trivin C., Brauner R. Pituitary apoplexy in an adolescent with prolactin secreting adenoma. Horm. Res. 50:1998;38-41
11. Alhajje A., Lambert M., Crabbe J. Pituitary apoplexy in an acromegalic patient during bromocriptine therapy. J. Neurosurg. 63:1985;288-292